Litcius/Paper detail

TGF-βR inhibitor SB431542 restores immune suppression induced by regulatory B–T cell axis and decreases tumour burden in murine fibrosarcoma

Kavitha Premkumar, Bhavani S. Shankar

2020Cancer Immunology Immunotherapy28 citationsDOIOpen Access PDF

Topics & Concepts

CD19IL-2 receptorRegulatory B cellsFibrosarcomaImmune systemCancer researchBiologyImmunologyCytotoxic T cellT cellImmunotherapyAntigenInterleukin 10In vitroGeneticsBiochemistryImmunotherapy and Immune ResponsesCancer Immunotherapy and BiomarkersImmune cells in cancer
TGF-βR inhibitor SB431542 restores immune suppression induced by regulatory B–T cell axis and decreases tumour burden in murine fibrosarcoma | Litcius